| |
Remark |
G Protein-coupled receptors
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
|
|
Transporters
|
ABC transporters
|
Solute carrier family
|
SLC5
|
SLC6
|
SLC9
|
SLC12
|
SLC12A1 [HSA:6557] [KO:K14425]
|
SLC12A2 [HSA:6558] [KO:K10951] [TC:2.A.30.3.1]
|
SLC12A3 [HSA:6559] [KO:K14426] [TC:2.A.30.4.2]
|
Bendroflumethiazide [ATC:C03AA01]
|
Hydroflumethiazide [ATC:C03AA02]
|
Hydrochlorothiazide [ATC:03AA03]
|
Chlorothiazide [ATC:C03AA04]
|
Polythiazide [ATC:C03AA05]
|
Trichlormethiazide [ATC:C03AA06]
|
Methyclothiazide [ATC:C03AA08]
|
Quinethazone [ATC:C03BA02]
|
Chlortalidone [ATC:C03BA04]
|
Mefruside [ATC:C03BA05]
|
Metolazone [ATC:C03BA08]
|
Meticrane [ATC:C03BA09]
|
D01605 Meticrane (JP16/INN)
|
Inhibitor
|
Indapamide [ATC:C03BA11]
|
Benzthiazide
|
Benzylhydrochlorothiazide
|
Penflutizide
|
SLC22
|
SLC29
|
Major facilitator superfamily
|
Others
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|